NCT03089086View on ClinicalTrials.gov

South Australian Meningococcal B Vaccine Herd Immunity Study

PHASE4CompletedINTERVENTIONAL
Enrollment

34,489

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

July 13, 2018

Study Completion Date

December 31, 2018

Conditions
Meningococcal Disease
Interventions
BIOLOGICAL

Licensed 4CMenB vaccine

Two doses (0.5 mL each) of Bexsero ® vaccine at least 1 month to \<3 months apart in adolescents.

Trial Locations (1)

5006

Vaccinology & Immunology Research Trials Unit, North Adelaide

All Listed Sponsors
collaborator

SA Health

OTHER

lead

University of Adelaide

OTHER

NCT03089086 - South Australian Meningococcal B Vaccine Herd Immunity Study | Biotech Hunter | Biotech Hunter